Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

G. John Aunins


  • Chief Technology Officer & Evp at Seres Therapeutics Inc. (MCRB), 2020-01-31
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MCRB $6.39 14,282 Officer 75,250 2018-12-17 Filing
MCRB $8.26 14,279 Officer 89,532 2018-11-15 Filing
MCRB $5.94 14,279 Officer 103,811 2018-10-15 Filing
MCRB $7.27 14,279 Officer 118,090 2018-09-17 Filing
MCRB $7.57 14,279 Officer 132,369 2018-08-15 Filing